| N | Percentage (%) | IL2RA mRNA expression range | Median | IL2RA mRNA expression Mean ± SE | p-value |
---|---|---|---|---|---|---|
Total | 239 | Â | Â | Â | Â | Â |
Age group | 0.312 | |||||
 15–29 | 65 | 27.2 | 0.0014–3.780 | 0.0128 | 0.211 ± 0.603 |  |
 30–49 | 113 | 47.3 | 0.0006–7.056 | 0.0097 | 0.304 ± 1.092 |  |
 50–65 | 61 | 25.5 | 0.0013–12.870 | 0.0130 | 0.598 ± 2.184 |  |
Gender | 0.973 | |||||
 Male | 127 | 53.1 | 0.0006–12.870 | 0.0105 | 0.395 ± 1.573 |  |
 Female | 112 | 46.9 | 0.0006–6.140 | 0.0122 | 0.306 ± 1.108 |  |
Blast percentage (%) | 0.941 | |||||
 ≥ 50 | 149 | 62.3 | 0.0006–8.540 | 0.0113 | 0.349 ± 1.247 |  |
 20–49 | 90 | 37.7 | 0.0006–12.870 | 0.0114 | 0.361 ± 1.566 |  |
WBC count | 0.684 | |||||
 ≥ 30 billion/L; high | 58 | 34.7 | 0.0007–5.890 | 0.0136 | 0.341 ± 1.060 |  |
 < 30 billion/L; low | 109 | 65.3 | 0.0006–12.870 | 0.0106 | 0.430 ± 1.649 |  |
AML type | 0.605 | |||||
 De novo AML | 231 | 96.7 | 0.0006–12.870 | 0.0113 | 0.353 ± 1.392 |  |
 Secondary AML | 8 | 3.3 | 0.0033–1.560 | 0.0258 | 0.365 ± 0.642 |  |
Fab subtypes | 0.279 | |||||
 Fab M0 | 6 | 2.6 | 0.0026–0.0468 | 0.0123 | 0.0172 ± 0.0161 |  |
 Fab M1 | 32 | 13.6 | 0.0013–6.140 | 0.0136 | 0.402 ± 1.474 |  |
 Fab M2 | 118 | 50.2 | 0.0006–4.120 | 0.0096 | 0.146 ± 0.576 |  |
 Fab M4 | 43 | 18.3 | 0.0007–12.870 | 0.0175 | 0.605 ± 2.097 |  |
 Fab M5 | 26 | 11.1 | 0.0006–8.540 | 0.0060 | 0.689 ± 1.981 |  |
 Fab M6 | 10 | 4.3 | 0.0020–7.056 | 0.0521 | 0.749 ± 2.216 |  |
 ND | 4 |  |  |  |  |  |
Cytogenetics groups | 0.141 | |||||
 Favorable-risk (CBF) | 54 | 22.6 | 0.0006–3.780 | 0.0137 | 0.138 ± 0.543 |  |
 Intermediate-risk | 148 | 61.9 | 0.0006–12.870 | 0.0096 | 0.417 ± 1.547 |  |
 Poor-risk | 37 | 15.5 | 0.0026–7.056 | 0.0170 | 0.416 ± 1.473 |  |
Flt3-ITD | 0.001 | |||||
 Flt3-ITD+ | 38 | 19.8 | 0.0006–12.870 | 0.0820 | 0.871 ± 2.275 |  |
 Flt3-ITD− | 154 | 80.2 | 0.0006–7.056 | 0.0105 | 0.205 ± 0.918 |  |
NPM1 | 0.818 | |||||
 NPM1+ | 36 | 18.8 | 0.0013–12.870 | 0.0117 | 0.452 ± 2.137 |  |
 NPM1− | 156 | 81.2 | 0.0006–7.056 | 0.0114 | 0.310 ± 1.058 |  |
NPM1+FLT3-ITD− | 0.015 | |||||
NPM1+FLT3-ITD− | 22 | 11.4 | 0.0013–0.0386 | 0.0056 | 0.0104 ± 0.0102 |  |
NonNPM1+FLT3-ITD− | 170 | 88.6 | 0.0006–12.870 | 0.0128 | 0.377 ± 1.396 |  |
CEBPA | 0.034 | |||||
 CEBPADM+ | 19 | 9.9 | 0.0006–0.0848 | 0.0056 | 0.0138 ± 0.0197 |  |
 CEBPADM− | 173 | 90.1 | 0.0006–12.870 | 0.0126 | 0.372 ± 1.389 |  |